Chengshui Chen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
-
- Neonatal Respiratory Health Research
Papers in
-
- Fibroblast Growth Factor Research 9
- Heme Oxygenase-1 and Carbon Monoxide 6
-
- Neonatal Respiratory Health Research 14
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Co-authors
- Xiangdong Wang (9 shared papers)Lin Shi (5 shared papers)Nian Dong (12 shared papers)Xiangdong Wang (8 shared papers)Yuping Li (12 shared papers)Savério Bellusci (15 shared papers)Jin‐San Zhang (16 shared papers)Shuanying Yang (1 shared paper)
- Journals
- Cell Biology and Toxicology (5 papers)International Immunopharmacology (5 papers)Frontiers in Cell and Developmental Biology (4 papers)Journal of Cellular and Molecular Medicine (4 papers)Cells (3 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Chengshui Chen
88 papers receiving 1.5k citations
Chengshui Chen's Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 167
- Pulmonary and Respiratory Medicine 324
- Molecular Biology 636
- Immunology 141
- Infectious Diseases 120
Countries citing papers authored by Chengshui Chen
This map shows the geographic impact of Chengshui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengshui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengshui Chen more than expected).
Fields of papers citing papers by Chengshui Chen
This network shows the impact of papers produced by Chengshui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengshui Chen. The network helps show where Chengshui Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chengshui Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications Hit paper breakdown → | 2022 | 163 |
| 2 | 2016 | 83 | |
| 3 | 2016 | 69 | |
| 4 | 2014 | 65 | |
| 5 | 2014 | 52 | |
| 6 | 2013 | 51 | |
| 7 | 2020 | 45 | |
| 8 | 2016 | 41 | |
| 9 | Thalidomide Combined with Low-dose Glucocorticoid in the Treatment of COVID-19 Pneumonia | 2020 | 39 |
| 10 | 2015 | 36 | |
| 11 | 2019 | 34 | |
| 12 | 2017 | 33 | |
| 13 | 2019 | 33 | |
| 14 | 2014 | 29 | |
| 15 | 2020 | 29 | |
| 16 | 2020 | 27 | |
| 17 | 2024 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2021 | 24 | |
| 20 | 2014 | 23 |
About Chengshui Chen
Chengshui Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Immunology and Cancer Research, having authored 94 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neonatal Respiratory Health Research (14 papers), Fibroblast Growth Factor Research (9 papers), Congenital Diaphragmatic Hernia Studies (7 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), MicroRNA in disease regulation (6 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Cancer Research (167 citations), Pulmonary and Respiratory Medicine (324 citations), Molecular Biology (636 citations), Immunology (141 citations) and Infectious Diseases (120 citations). Chengshui Chen has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiangdong Wang, Lin Shi, Nian Dong, Xiangdong Wang, Yuping Li, Savério Bellusci, Jin‐San Zhang, Shuanying Yang, Xiaokun Li and Chunxue Bai. Their work appears in journals such as Cell Biology and Toxicology, International Immunopharmacology, Frontiers in Cell and Developmental Biology, Journal of Cellular and Molecular Medicine and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.